Skip to main content
BrightSpring Q3 revenue skyrockets 26% to $4.21 billion
Image for illustrative purposes only. Not a real photo.

BrightSpring Q3 revenue skyrockets 26% to $4.21 billion

Share

Key points

  • BrightSpring Health Services (NASDAQ:BTSG) reported third-quarter 2026 revenue of $4.213 billion, up 26% year over year.
  • Continuing-operations net income increased to $100.8 million, from $37.5 million, while adjusted EBITDA rose 42% to $228 million.
  • BrightSpring raised its 2026 financial guidance, projecting revenue of $15.9 billion–$16.125 billion and adjusted EBITDA of $850 million–$860 million.

BrightSpring Health Services (NASDAQ:BTSG) reported third-quarter 2026 revenue of $4.213 billion, up 26% year over year, as continuing-operations net income increased to $100.8 million.

The company reported diluted continuing-operations earnings per share of $0.46, compared with $0.17 a year earlier, while adjusted EBITDA increased 42% to $228 million.

The company reported that growth across its Pharmacy Solutions and Provider Services businesses contributed to the quarterly performance.

Pharmacy Solutions revenue increased 26% to $3.732 billion, while Provider Services revenue rose 31% to $481 million, and the company's leverage ratio declined to 1.79x from 2.15x at June 30, 2026.

BrightSpring raised its 2026 revenue forecast to $15.9 billion–$16.125 billion and adjusted EBITDA guidance to $850 million–$860 million, excluding its divested Community Living business and future closed acquisitions.

The company expects the acquisition of Amedisys and LHC branches to contribute approximately $35 million in adjusted EBITDA during 2026.

BrightSpring provides pharmacy and home- and community-based healthcare services, with its business operations divided primarily between Pharmacy Solutions and Provider Services.


Frequently asked questions